Wall Street is cheering the news that a viable coronavirus treatment could be on the horizon after a pair of studies showed a drug from Gilead Sciences worked in patients.
"Put down the bleach, remdesivir is coming," JPMorgan's biotech analyst Cory Kasimov said in a note to clients on Wednesday.
The analyst's comment is a tongue-in-cheek reference to President Donald Trump's words last week about injecting disinfectants into the body. The president later said he was being sarcastic.